SP Group A/S
Share Buy-back program at SP Group A/S
On 15 September, 2020 SP Group initiated a share buy-back programme, cf. company announcement no. 37/2020 of 15 September 2020. The share buy-back programme has been extended according to company announcement no. 6/2021 with DKK 25 million. According to the programme, SP Group will in the period from 15 September 2020 until 10 April 2021 purchase own shares for a maximum amount of DKK 65.0 million.
The share buy-back programme was initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014 about Market Abuse, the so-called Market Abuse Regulation that protects listed companies’ board and executive board against violation of insider legislation in connection with share buy-backs.
Attachment
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ORPHAZYME A/S1.3.2021 07:02:06 CET | Press release
Orphazyme appoints Christophe Bourdon as Chief Executive Officer
Idorsia Pharmaceuticals Ltd1.3.2021 07:01:56 CET | Press release
Idorsia submits NDA for clazosentan to Japanese PMDA
Hexagon Composites ASA1.3.2021 07:01:46 CET | Press release
Hexagon Agility receives additional order from major global logistics customer for CNG trucks
Santhera Pharmaceuticals Holding AG1.3.2021 07:01:36 CET | Press release
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
Arcadis N.V.1.3.2021 07:01:26 CET | Press release
Arcadis finds U.S., Singapore, and Japan most attractive places to build data centers
Junshi Biosciences1.3.2021 02:16:51 CET | Press release
Junshi Biosciences and AstraZeneca Announce Strategic Collaboration to Commercialize Toripalimab in China
Anoto Group AB28.2.2021 23:46:27 CET | Press release
Year-end report January – December 2020
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom